Compounds > acetylcysteine

acetylcysteine and Sarcoma

acetylcysteine has been researched along with Sarcoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berruti, A; Bianchi, S; Consoli, F; Cosentini, D; Ferrari, VD; Grisanti, S; Lazzari, B; Roca, E; Tovazzi, V1
Grdina, DJ; Miller, RC; Murley, JS1
Barrett, JC; French, JE; Kari, FW; Martin, KR; Saulnier, MJ1
Barr, LH; Bonow, RO; d'Angelo, T; Dresdale, AR; Mathisen, DJ; Myers, CE; Rosenberg, SA; Schwartz, DE1
Benjamin, RS; Legha, SS; Nicaise, C; Patel, SR1
Ayele, W; Benvenuto, JA; Legha, SS; Newman, RA; Nicaise, C; Raber, MN1

Reviews

1 review(s) available for acetylcysteine and Sarcoma

ArticleYear
Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
    Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2

    Topics: Acetylcysteine; Bone Neoplasms; Fluid Therapy; Humans; Ifosfamide; Mesna; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urinary Bladder Diseases

1993

Trials

1 trial(s) available for acetylcysteine and Sarcoma

ArticleYear
Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy.
    American journal of clinical oncology, 1982, Volume: 5, Issue:6

    Topics: Acetylcysteine; Adolescent; Adult; Cardiomyopathies; Child; Doxorubicin; Female; Heart Function Tests; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Sarcoma; Soft Tissue Neoplasms

1982

Other Studies

4 other study(ies) available for acetylcysteine and Sarcoma

ArticleYear
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:8

    Topics: Acetylcysteine; Antineoplastic Agents, Alkylating; Disease-Free Survival; Female; Humans; Liver; Male; Middle Aged; Retrospective Studies; Sarcoma; Trabectedin

2018
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs.
    Radiation research, 2014, Volume: 181, Issue:5

    Topics: Acetylcysteine; Acute Radiation Syndrome; Amifostine; Animals; Captopril; Cell Line, Transformed; Cell Line, Tumor; Cells, Cultured; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Drug Synergism; Endothelial Cells; Fibroblasts; Free Radical Scavengers; Humans; Mesna; Metformin; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Radiation Injuries, Experimental; Radiation-Protective Agents; Sarcoma; Sulfhydryl Compounds

2014
Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progression.
    Nutrition and cancer, 2002, Volume: 43, Issue:1

    Topics: Acetylcysteine; Animals; Antioxidants; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cross-Over Studies; Dietary Supplements; Disease Models, Animal; Female; Free Radical Scavengers; Genes, ras; Linear Models; Male; Mice; Mice, Transgenic; Sarcoma; Skin Neoplasms; Survival Rate; Time Factors

2002
Clinical pharmacokinetics of ifosfamide in combination with N-acetylcysteine.
    Anti-cancer drugs, 1992, Volume: 3, Issue:1

    Topics: Acetylcysteine; Agranulocytosis; Bone Marrow; Humans; Ifosfamide; Sarcoma

1992